Oak Beast
A rare, poorly documented hybrid strain with limited verifiable data on its chemistry, lineage, or effects.
Oak Beast is one of those strains where the marketing outruns the evidence. It shows up in a few seedbank listings and dispensary menus, but there is no peer-reviewed chemistry, no verified breeder documentation we could locate, and no independent lab data aggregated at scale. Everything below is either general cannabis science or clearly labeled folklore. If a budtender tells you Oak Beast will do X specifically, they are guessing. Buy it because you liked the last jar, not because of the name.
Overview
Oak Beast is a cannabis strain name that circulates in small-scale seed and flower listings, primarily in North American markets. Unlike widely characterized cultivars such as OG Kush or Blue Dream, Oak Beast has no entry in major cannabinoid/terpene reference datasets we could verify, and no breeder has published a lineage record with provenance we can confirm No data.
That matters. Cannabis strain names are not regulated trademarks in most jurisdictions, and genetic testing has repeatedly shown that flower sold under the same name can differ substantially between growers [1][2]. For a rare name like Oak Beast, you should assume the label tells you very little about what is actually in the jar.
Chemistry
We could not locate published certificate-of-analysis aggregates, peer-reviewed chemotype data, or independent lab panels for Oak Beast No data. Any THC, CBD, or terpene numbers you see on a menu reflect a single batch from a single grower, not a stable cultivar average.
Generally, modern hybrid flower in legal markets tests between roughly 15% and 25% THC with CBD typically under 1% [3]. Terpene profiles vary widely even within a named cultivar because they are shaped by genetics, phenotype selection, environment, and curing [4]. Until someone publishes chemotype data on Oak Beast specifically, treat vendor claims about a "dominant terpene" as unverified No data.
Reported effects
There is no strain-specific clinical trial for Oak Beast, and there almost certainly never will be — this is true for essentially every named cannabis cultivar No data. What people report anecdotally on forums and dispensary reviews is a mix of expectation, dose, setting, tolerance, and the chemistry of whatever specific batch they consumed Anecdote.
The broader science is clearer: acute effects of inhaled cannabis are driven mainly by THC dose, with modulation from other cannabinoids and possibly terpenes, though the "entourage effect" remains only partially supported by controlled human data [5][6]. The popular indica-vs-sativa framework does not reliably predict effects and is not supported by chemotype analysis [1] Strong evidence. So if Oak Beast is marketed as "a heavy indica couch-lock," that is folklore, not chemistry.
Lineage
Lineage claims for Oak Beast are inconsistent across the small number of vendor pages that mention it, and we could not find a breeder statement with verifiable provenance Disputed. This is a common pattern for boutique or regional strain names: multiple growers may attach the same name to unrelated genetics, or reconstruct a lineage story after the fact.
Genetic studies of the commercial cannabis supply have found that many strains sharing a name do not share a close genetic relationship, and lineage claims frequently do not match DNA evidence [1][2]. Until Oak Beast is genotyped and cross-referenced, treat any parent-strain claim (e.g. "crossed with [famous strain]") as marketing until proven otherwise.
Cultivation basics
We do not have verified cultivation data for Oak Beast — no documented flowering time, yield, height, stretch, or difficulty rating from a breeder we can identify No data. General guidance for growing an unknown hybrid indoors:
- Expect 8–10 weeks of flowering as a baseline for most photoperiod hybrids [7].
- Start with moderate feeding; unknown genetics may or may not tolerate heavy nutrients.
- Take clones early if you find a phenotype you like, because seed-grown Oak Beast plants will vary and the name provides no guarantee of consistency across a pack.
If you are buying flower rather than growing, the cultivation section is largely irrelevant — what matters is the specific grower and their COA.
Marketing vs. reality
The gap between what strain names promise and what they deliver is one of the most consistent findings in cannabis research [1][2] Strong evidence. For Oak Beast specifically:
- "Rare / exclusive": Often true in the trivial sense that few vendors carry it, but rarity is not a quality signal.
- "Indica-dominant" or "sativa-leaning": Not predictive of effects [1] Strong evidence.
- "High-myrcene, couch-lock": The idea that >0.5% myrcene guarantees sedation is folklore with no controlled evidence behind the specific threshold No data.
- Named parent lineage: Unverified for Oak Beast Disputed.
Bottom line: if you enjoy a particular jar labeled Oak Beast, great — but the honest answer is that the name is doing very little work. Trust the COA and your own experience, not the branding.
Sources
- Peer-reviewed Watts, S., McElroy, M., Migicovsky, Z., Maassen, H., van Velzen, R., & Myles, S. (2021). Cannabis labelling is associated with genetic variation in terpene synthase genes. Nature Plants, 7(10), 1330–1334.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1(3).
- Peer-reviewed ElSohly, M. A., Chandra, S., Radwan, M., Majumdar, C. G., & Church, J. C. (2021). A comprehensive review of cannabis potency in the United States in the last decade. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 6(6), 603–606.
- Peer-reviewed Booth, J. K., & Bohlmann, J. (2019). Terpenes in Cannabis sativa – from plant genome to humans. Plant Science, 284, 67–72.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Cogan, P. S. (2020). The 'entourage effect' or 'hodge-podge hashish': the questionable rebranding, marketing, and expectations of cannabis polypharmacy. Expert Review of Clinical Pharmacology, 13(8), 835–845.
- Book Cervantes, J. (2015). The Cannabis Encyclopedia: The Definitive Guide to Cultivation & Consumption of Medical Marijuana. Van Patten Publishing.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...